|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.440 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (2,349) | 19,633 | (6,939) | 58,905 |
| Net Cash from / (used in) Investing Activities | -- | (122,106) | (220,710) | (144,620) | 7,148 |
| Net Cash from / (used in) Financing Activities | -- | 153,839 | 199,548 | 76,745 | (49,756) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 29,384 | (1,529) | (74,814) | 16,297 |
| Cash & Cash Equivalents at beginning of period | -- | 59,993 | 58,178 | 133,693 | 119,316 |
| Effect of Foreign Exchange Rate Changes | -- | 177 | 3,344 | (701) | (1,920) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 89,554 | 59,993 | 58,178 | 133,693 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -18,786,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.035 |
| NBV Per Share (¥) | RMB 1.195 |